{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:51:43Z","timestamp":1793386303302,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jbo.2025.100701","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:25:09Z","timestamp":1752611109000},"page":"100701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Yin Yang 1 protein-activated N-acetyltransferase 10 drives cell malignant progression of osteosarcoma through ac4C acetylation of integrin \u03b23"],"prefix":"10.1016","volume":"53","author":[{"given":"Fan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.jbo.2025.100701_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1387\/ijdb.190019us","article-title":"On the biomechanical properties of osteosarcoma cells and their environment","volume":"63","author":"Muller","year":"2019","journal-title":"Int. J. Dev. Biol."},{"issue":"Suppl 2","key":"10.1016\/j.jbo.2025.100701_b0010","article-title":"Osteosarcoma","volume":"68","author":"Eaton","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"issue":"2","key":"10.1016\/j.jbo.2025.100701_b0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/bph.15713","article-title":"Osteosarcoma mechanobiology and therapeutic targets","volume":"179","author":"Shoaib","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.jbo.2025.100701_b0020","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.2174\/1570180820666230418113909","article-title":"Ezetimibe inhibits cell viability and invasion by suppressing PI3K\/AKT signaling pathway in human osteosarcoma cells","volume":"21","author":"Yong","year":"2024","journal-title":"Lett. Drug Des. Discovery"},{"issue":"5","key":"10.1016\/j.jbo.2025.100701_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189171","article-title":"Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma","volume":"1879","author":"Yan","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"9","key":"10.1016\/j.jbo.2025.100701_b0030","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1007\/s00432-023-04614-4","article-title":"Targeted therapy for osteosarcoma: a review","volume":"149","author":"Li","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.jbo.2025.100701_b0035","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1080\/15476286.2020.1722449","article-title":"RNA modifications and cancer","volume":"17","author":"Haruehanroengra","year":"2020","journal-title":"RNA Biol."},{"key":"10.1016\/j.jbo.2025.100701_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108576","article-title":"Emerging roles of RNA ac4C modification and NAT10 in mammalian development and human diseases","volume":"253","author":"Zhang","year":"2024","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.jbo.2025.100701_b0045","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1261\/rna.079948.124","article-title":"ac4C: a fragile modification with stabilizing functions in RNA metabolism","volume":"30","author":"Schiffers","year":"2024","journal-title":"RNA"},{"issue":"Pt 2","key":"10.1016\/j.jbo.2025.100701_b0050","article-title":"The emerging roles of ac4C acetylation \u201cwriter\u201d NAT10 in tumorigenesis: a comprehensive review","volume":"254","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.jbo.2025.100701_b0055","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","article-title":"NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer","volume":"83","author":"Xie","year":"2023","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.jbo.2025.100701_b0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41422-023-00793-4","article-title":"Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner","volume":"33","author":"Liao","year":"2023","journal-title":"Cell Res."},{"issue":"7","key":"10.1016\/j.jbo.2025.100701_b0065","doi-asserted-by":"crossref","first-page":"8452","DOI":"10.1002\/cam4.5585","article-title":"ITGB3 promotes cisplatin resistance in osteosarcoma tumors","volume":"12","author":"Li","year":"2023","journal-title":"Cancer Med."},{"issue":"2","key":"10.1016\/j.jbo.2025.100701_b0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1568009615666150131124200","article-title":"The role of YY1 in oncogenesis and its potential as a drug target in cancer therapies","volume":"15","author":"Shi","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.jbo.2025.100701_b0075","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13062-024-00486-x","article-title":"METTL3 promotes the progression of osteosarcoma through the N6-methyladenosine modification of MCAM via IGF2BP1","volume":"19","author":"Song","year":"2024","journal-title":"Biol. Direct"},{"issue":"1","key":"10.1016\/j.jbo.2025.100701_b0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3727\/096504008784046081","article-title":"Silencing of YY1 downregulates RIZ1 promoter in human osteosarcoma","volume":"17","author":"Abbondanza","year":"2008","journal-title":"Oncol. Res."},{"key":"10.1016\/j.jbo.2025.100701_b0085","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.omtn.2023.03.023","article-title":"Mechanisms of NAT10 as ac4C writer in diseases","volume":"32","author":"Xie","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.jbo.2025.100701_b0090","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31474","article-title":"NAT10 functions as a pivotal regulator in gastric cancer metastasis and tumor immunity","volume":"240","author":"Mo","year":"2025","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.jbo.2025.100701_b0095","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2023.2274143","article-title":"NAT10 promotes the tumorigenesis and progression of laryngeal squamous cell carcinoma through ac4C modification of FOXM1 mRNA","volume":"24","author":"Li","year":"2023","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.jbo.2025.100701_b0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41420-023-01355-8","article-title":"Role of NAT10-mediated ac4C-modified HSP90AA1 RNA acetylation in ER stress-mediated metastasis and lenvatinib resistance in hepatocellular carcinoma","volume":"9","author":"Pan","year":"2023","journal-title":"Cell Death Discov"},{"issue":"32","key":"10.1016\/j.jbo.2025.100701_b0105","article-title":"NAT10 promotes prostate cancer growth and metastasis by acetylating mRNAs of HMGA1 and KRT8","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"issue":"5","key":"10.1016\/j.jbo.2025.100701_b0110","doi-asserted-by":"crossref","first-page":"e738","DOI":"10.1002\/ctm2.738","article-title":"NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression","volume":"12","author":"Wang","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"12","key":"10.1016\/j.jbo.2025.100701_b0115","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/cac2.12363","article-title":"N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA","volume":"42","author":"Zheng","year":"2022","journal-title":"Cancer Commun. (Lond)"},{"issue":"3","key":"10.1016\/j.jbo.2025.100701_b0120","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41419-018-0322-6","article-title":"G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner","volume":"9","author":"Hu","year":"2018","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.jbo.2025.100701_b0125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/cbin.12104","article-title":"The role of thrombomodulin in modulating ITGB3 expression and its implications for triple-negative breast cancer progression","volume":"48","author":"Chang","year":"2024","journal-title":"Cell Biol. Int."},{"issue":"3","key":"10.1016\/j.jbo.2025.100701_b0130","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ijc.31255","article-title":"The Yin and Yang of YY1 in tumor growth and suppression","volume":"143","author":"Khachigian","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.jbo.2025.100701_b0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12935-024-03262-z","article-title":"YY1: a key regulator inhibits gastric cancer ferroptosis and mediating apatinib-resistance","volume":"24","author":"Geng","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"6","key":"10.1016\/j.jbo.2025.100701_b0140","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/cam4.1073","article-title":"YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress","volume":"6","author":"Qu","year":"2017","journal-title":"Cancer Med."},{"issue":"6","key":"10.1016\/j.jbo.2025.100701_b0145","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1158\/0008-5472.CAN-07-5582","article-title":"Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4\/angiogenesis and metastasis","volume":"68","author":"de Nigris","year":"2008","journal-title":"Cancer Res."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137425000429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137425000429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:34:56Z","timestamp":1762605296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137425000429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":29,"alternative-id":["S2212137425000429"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2025.100701","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yin Yang 1 protein-activated N-acetyltransferase 10 drives cell malignant progression of osteosarcoma through ac4C acetylation of integrin \u03b23","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2025.100701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100701"}}